Twist Bioscience Expands Synthetic Viral Controls Portfolio With Launch Of Synthetic RNA Control For H5N1 Influenza A; Covers 99.9% Of Hemagglutinin And Neuraminidase Genome Regions
Twist Bioscience Expands Synthetic Viral Controls Portfolio With Launch Of Synthetic RNA Control For H5N1 Influenza A; Covers 99.9% Of Hemagglutinin And Neuraminidase Genome Regions
twist bioscience擴展合成病毒控制組合，推出了H5N1流感A合成RNA控制; 覆蓋99.9%的血凝素和神經氨酸酶基因組區域
Twist Bioscience Expands Synthetic Viral Controls Portfolio With Launch Of Synthetic RNA Control For H5N1 Influenza A; Covers 99.9% Of Hemagglutinin And Neuraminidase Genome Regions
twist bioscience擴展合成病毒控制組合，推出了H5N1流感A合成RNA控制; 覆蓋99.9%的血凝素和神經氨酸酶基因組區域
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。